Nucleic Acids Research Review Time

NAR is often more predictable than broad journals because the editors are not trying to map every manuscript onto a vague prestige ladder. They are usually deciding whether the submission has a clear NAR identity: research article, tool, database, web server, or nucleic-acid biology paper with durable field value.

For a standard research article, the process usually breaks down like this:

• Editorial screening: about 1 to 3 weeks
• Reviewer invitation and acceptance: about 1 week
• Active review: about 3 to 4 weeks
• First decision letter: around day 45

That 45-day estimate lines up with the journal data already tracked in Manusights for the Nucleic Acids Research profile. It's also a believable number for a journal that relies on specialist reviewers who can judge both method quality and biological relevance.

If your paper is accepted after one major revision, a realistic full timeline is 45 days to first decision, 4 to 8 weeks for your revision, 2 to 4 weeks for re-review or editorial assessment, and 1 to 3 weeks for final acceptance and production steps. That puts many successful papers in the 4-month zone.

NAR has a narrower mission than a generalist journal. Editors know what they're looking for. The journal is strong in gene regulation, DNA repair, RNA biology, genomics resources, databases, and web servers. That helps. Scope confusion is lower than it is at broad molecular biology journals.

It also helps that many NAR submissions fall into recognizable buckets. A database article needs clear community utility. A web tool needs stable access and documentation. A mechanistic RNA paper needs strong experiments and a clear contribution. Reviewers can assess those categories quickly when the manuscript is well prepared.

The journal's JIF is 13.1 in JCR 2024, with a 5-year JIF of 16.8. That official JCR 2024 figure matters because NAR is selective enough that editors are not trying to fill pages with borderline work.

The trend helps explain why NAR can move quickly on scope decisions without lowering the bar for utility or rigor.

The JIF is down from 19.2 in 2021 to 13.1 in 2024, but it has also been flat from 13.1 in 2023 to 13.1 in 2024. Together with the 16.8 five-year JIF, that tells authors NAR is still rewarding papers with long-tail community use rather than short-lived citation spikes.

• Tool papers with weak benchmarking. If you claim a method is better than existing tools but only compare against one baseline or one dataset, reviewers will ask for more.

• Computational work with no biological validation. Predictions without confirmation tend to trigger extra reviewer demands.

• Structural work without mechanism. A structure alone is often not enough.

• Database submissions with unclear maintenance plans. If the resource won't obviously stay online and usable, reviewers notice.

• Reviewer scarcity. Bioinformatics papers sometimes need one reviewer who understands the algorithm and another who understands the biology.

• State the use case early. If you built a tool, explain who will use it, for what, and why current tools fall short.

• Benchmark like you expect pushback. Multiple datasets, clear baselines, practical metrics. Not just accuracy.

• Include reproducibility details on day one. Code links, access instructions, data deposition, and enough methods for another lab to rerun the work.

• Make figures self-explanatory. NAR papers often live or die on whether a reviewer can decode the figures fast.

• Suggest sensible reviewers. Pick active people who publish in the same technical lane.

If you cut corners here, the review doesn't just get harsher. It gets slower.

• Under 6 weeks: normal
• 6 to 8 weeks: still normal
• Over 8 weeks: reasonable time for a short inquiry
• Over 10 weeks: likely reviewer delay or editor backlog

Keep the email short. One paragraph is enough.

In our pre-submission review work with manuscripts targeting NAR, three patterns generate the most consistent desk rejections or revision-heavy outcomes.

Tool papers without enough benchmarking or real-user evidence. According to SciRev community data on NAR, immediate rejection averages about 2 days. We see the same speed when a tool paper claims utility but has not shown enough comparisons against current field standards. In our experience, roughly 35% of NAR manuscripts we review need broader benchmarking before the utility claim feels secure.

Computational papers with weak biological validation. NAR will publish strong computational work, but the paper still needs a clear nucleic-acid or molecular-biology payoff. In our experience, roughly 30% of NAR manuscripts we audit would move faster through review if the biological validation were visible earlier in the package instead of buried in the supplement or left for revision.

Database or web-resource submissions without a long-term maintenance story. OUP's author guidelines for NAR make it clear that category fit and submission requirements matter. We see this pattern in roughly 20% of NAR resource manuscripts: the science is real, but the editorial package does not yet make the maintenance, access, and field-use case strong enough for a journal whose reputation depends heavily on durable resources.

Published timelines are medians that mask real variation. Desk rejections skew the median down. Seasonal effects and field-specific reviewer availability affect your specific wait.

A NAR desk-rejection risk and review delay check identifies desk-reject risk before you submit.

Nucleic Acids Research (Oxford Academic, IF ~14) is the leading journal for nucleic acid research, molecular biology, and genomics. The review process includes academic editors who are active researchers in nucleic acid biology.

NAR publishes a special Database Issue each January and a Web Server Issue each July, these are invitation-only and have separate timelines. Regular research articles follow standard peer review.

NAR does not accept papers that use nucleic acids as tools without contributing to nucleic acid biology. Sequencing studies that generate data but do not provide mechanistic insight into nucleic acid function belong at Genome Research or Bioinformatics.

A NAR desk-rejection risk check scores desk-reject risk.